Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Provectus Biopharmaceuticals Inc PVCT

Healthcare
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). The Company’s lead molecule is named rose bengal sodium (RBS). The Company’s small molecule HX medical science platform... see more

Recent & Breaking News (OTCQB:PVCT)

Provectus' Intralesional PV-10 Clinical Data Published in the Annals of Surgical Oncology

Business Wire October 28, 2014

Q&A with Provectus Biopharmaceutical's COO/CFO, Peter Culpepper

Accesswire October 20, 2014

Provectus' Intralesional PV-10 Clinical Data to Be Presented to the 2014 International Congress of the Society for Melanoma Research

Business Wire October 16, 2014

Provectus' Intralesional PV-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting

Business Wire October 15, 2014

INC Research Signs Agreement to Perform FDA Due Diligence Audit of Regulatory Documents for Provectus Biopharmaceuticals

Business Wire October 14, 2014

Provectus' Intralesional PV-10 Clinical Data to Be Presented to the Eurasian Federation of Oncology

Business Wire October 8, 2014

Provectus' Intralesional PV-10 to Be Presented at the 2014 Beijing International Melanoma Congress

Business Wire October 7, 2014

Provectus Biopharmaceuticals Data Presented At ESMO 2014 Congress Show Ablative, Bystander Effects Of PV-10

Business Wire September 29, 2014

Provectus Biopharmaceuticals' PV-10 Clinical Data on Melanoma Now Available for European Society for Medical Oncology 2014 Congress

Business Wire September 24, 2014

Provectus' Intralesional Pv-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting

Business Wire September 23, 2014

Provectus Biopharmaceuticals Appoints Christopher Kaplan to Its Strategic Advisory Board

Business Wire September 22, 2014

Leading Health Care Stock for Small-Cap Stars is Provectus Biopharmaceuticals Inc. (PVCT) for August 25

Equities.com August 25, 2014

Leading Health Care Stock for Small-Cap Stars is Boston Therapeutics Inc (BTHE) for August 22

Equities.com August 22, 2014

Leading Health Care Stock for Small-Cap Stars is Provectus Biopharmaceuticals Inc. (PVCT) for August 18

Equities.com August 18, 2014

Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, and Sinopharm A-THINK Pharmaceutical Co., Ltd.

Business Wire August 18, 2014

Leading Small-Cap Stars Health Care Stock for August 18 Morning Session is Provectus Biopharmaceuticals Inc. (PVCT)

Equities.com August 18, 2014

Provectus Biopharmaceuticals Inc. (PVCT) Leads Small-Cap Stars in Early Trading for August 18

Equities.com August 18, 2014

Leading Small-Cap Stars Health Care Stock for August 15 Morning Session is Boston Therapeutics Inc (BTHE)

Equities.com August 15, 2014

Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly Conference Calls on Thursday, August 7, 2014

Business Wire August 6, 2014

PROVECTUS 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc. - PVCT

Marketwired July 25, 2014